An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics (Nasdaq: VTGN)

Expert Rev Neurother. 2020 Apr;20(4):311-312. doi: 10.1080/14737175.2020.1739858. Epub 2020 Mar 12.

Author

Affiliation

¹ Chief Executive Officer and Director of VistaGen Therapeutics.

PMID: 32141345
DOI: 10.1080/14737175.2020.1739858

No abstract available

Keywords: Central nervous system pharmaceuticals; PH94B nasal spray; VistaGen Therapeutics; social anxiety disorder.

Publication types

Interview